Stock Analysis of Longeveron LLC (LGVN) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code LGVN
Close 1.28
Change -0.0100 / 0.775 %
Volume 227705
Vol Change -119264.00 / 34.37 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Longeveron LLC
PE (TTM)

-31.45

Very Poor
Price / Book

77.28

Very Poor
Price / Sales

695.30

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

6198.73 K

Enterprise Value

1842.73 K

ROA (TTM)

-149.53

Very Poor
ROE (TTM)

-245.73

Very Poor
Net Margin (TTM)

-2210.84

Very Poor
Revenue

37.23 %

767000
Net Profit

5.35 %

-19842.00 K
Debt to Equity

0.088

Excellent
Altman Z Score

-14.32

Very Poor
Quick Ratio

0

Poor
Cash Ratio

1.38

Indecisive


Highs/Lows of Longeveron LLC
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.455 12.03 % 1.54 % 1.581.2414-May-2413-May-24
Two Week1.75 26.86 % 3.42 % 1.77081.2406-May-2413-May-24
One Month2.09 38.76 % 5.60 % 2.28971.2418-Apr-2413-May-24
Three Month5.3 75.85 % 5.95 % 5.8581.2427-Feb-2413-May-24
Six Months19.0 93.26 % 17.48 % 23.91.2407-Dec-2313-May-24
One year30.4 95.79 % 27.52 % 40.01.2416-Jun-2313-May-24
Two year91.2 98.60 % 29.70 % 45.791.2427-Jan-2313-May-24


Technical View of Longeveron LLC
RSI

31.71

Neutral
MACD

-0.371

Bullish
ADX

18.55

Neutral
Super Trend

2.00

Strong Bearish
Williams %R

-95.24

Mild Bearish
CCI

-142.21

Mild Bullish


EMA 5

1.34

Mild Bearish
EMA 15

1.55

Mild Bearish
EMA 50

2.92

Strong Bearish
EMA 100

6.15

Strong Bearish
SMA 100

5.33

Mild Bearish
SMA 200

13.73

Strong Bearish
SMA 5 / 20

1.32 / 1.61

Strong Bearish
SMA 15 / 50

1.55 / 2.60

Mild Bearish
SMA 50 / 200

2.60 / 13.73

Strong Bearish




Charts of Longeveron LLC


Returns of Longeveron LLC with Peers
Period / StockLGVNAIMDADILENVB
1 Week-12.03%-1.02%3.33%-5.62%
1 Mth-38.76%0%-33.19%-4.76%
3 Mth-75.85%25.30%34.78%1.08%
6mth-93.26%-65.33%-26.19%-44.00%
1 Year-95.79%-70.37%-81.44%-44.74%
2 Year-98.60%-95.54%-95.81%-92.35%
5 Years-13766.67%-97.26%-99.94%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Longeveron LLC with Peers
Ratio / StockLGVNAIMDADILENVB
PE-31.45-0.321-0.302-0.118
P/B77.280.1670.5340.478
ROA-149.53-43.66-121.53-159.98
ROE-245.73-52.02-176.69-406.87
Debt To Equity0.0880.24400
Revenue767000
37.23 % 		1140.23 K
67.60 % 		0
% 		0
%
Net Income-19842.00 K
5.35 % 		-9977.06 K
28.92 % 		-6069.70 K
52.32 % 		-22565.34 K
22.16 %


Technicals of Longeveron LLC with Peers
Technical / StockLGVNAIMDADILENVB-
ADX18.5532.0415.1535.12
CMF-0.376-0.118-0.2150.325
MFI47.6981.2552.0585.51
RSI31.7146.3446.7144.20
MACD Abv SignalTrueTrueFalseFalse
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Longeveron LLC

Address : Life Science and Technology Park, Miami, FL, United States, 33136
Tel : 305 909 0840
URL : https://longeveron.com
Code : LGVN, ISIN : US54303L1044, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 12_Feb_2021
Employee Count : 23

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.


Note : All Data Generated at the End of Trading Hours (EOD Data)